NCT04645329

Brief Summary

Reverse shoulder prostheses are the treatment of choice in elderly patients with rotator cuff arthropathy. Traditionally these patients have been immobilized for 3 weeks in the immediate postoperative period in order to have good pain control. However, there are no studies that determine the most appropriate period of immobilization. In fact, patients undergoing this type of surgery begin rehabilitation exercises within 24 hours of surgery without experiencing increased pain or requiring specific analgesic treatment. There is a demand in the elderly to limit immobilization time as much as possible, as some live alone and need to be self-sufficient and others have dependents. It would be good to know if it is really necessary to make an immobilization in these patients undergoing this type of surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 27, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

2.3 years

First QC Date

November 17, 2020

Last Update Submit

March 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Pain control (visual analogical scale)

    determination of pain control between groups at different time points with the aid of a visual analogical scale of 10 points, where 0 means no pain and 10 means maximum pain.

    determination of pain the day of the surgery, and then 24hours, 48hours, 7 days, 3-weeks, 3 months, 6 months, 1 year, 2 years postoperatively.

Study Arms (2)

group I (no immobilization)

EXPERIMENTAL

patients will be allowed to freely use their arm without any immobilization after surgery

Device: shoulder immovilization sling

group II (3-week immobilization)

ACTIVE COMPARATOR

patients will be kept in an immobilization device for three weeks after surgery

Device: shoulder immovilization sling

Interventions

immobilization of the arm after surgery

group I (no immobilization)group II (3-week immobilization)

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • patients undergoing primary surgery of inverted prosthesis for rotator cuff arthropathy.
  • age between 65-85 a.
  • without inflammatory pathologies (rheumatoid arthritis, psoriatic arthritis, ...)
  • acceptance to be part of the study.

You may not qualify if:

  • prosthetic surgery prior to the affected limb.
  • other indications of reverse prosthesis other than rotator cuff arthropathies (acute fractures, sequelae fractures, tumor surgery, prosthetic revision surgeries).
  • no acceptance to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital del Mar

Barcelona, 08003, Spain

RECRUITING

MeSH Terms

Conditions

Rotator Cuff Tear Arthropathy

Condition Hierarchy (Ancestors)

ChondrocalcinosisArthritisJoint DiseasesMusculoskeletal DiseasesCrystal Arthropathies

Study Officials

  • Carlos Torrens, MD, PhD

    Chief Clinic of Parc de Salut Mar

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carlos Torrens, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
outcomes assessor will be blinded to the allocation of the patients
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized prospective study. (computer-generated randomization list and saved in opaque envelopes)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

November 17, 2020

First Posted

November 27, 2020

Study Start

January 1, 2020

Primary Completion

April 30, 2022

Study Completion

April 30, 2024

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations